Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong · Delayed Price · Currency is HKD 31.16
+0.96 (3.18%)
Aug 21, 2026, 4:08 PM HKT
HKG:3378 Revenue
In the year 2025, Hanx Biopharmaceuticals (Wuhan) had annual revenue of 92.00K CNY, down -95.82%.
Revenue
92.00K CNY
Revenue Growth
-95.82%
P/S Ratio
41,459.47
Revenue / Employee
1.67K CNY
Employees
55
Market Cap
4.24B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 92.00K | -2.11M | -95.82% |
| Dec 31, 2024 | 2.20M | -340.00K | -13.39% |
| Dec 31, 2023 | 2.54M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.